Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

Gibbs LD, Vishwanatha JK.

Oncotarget. 2017 Dec 23;9(2):2697-2704. doi: 10.18632/oncotarget.23627. eCollection 2018 Jan 5.

2.

Measuring Light at Night and Melatonin Levels in Shift Workers: A Review of the Literature.

Hunter CM, Figueiro MG.

Biol Res Nurs. 2017 Jul;19(4):365-374. doi: 10.1177/1099800417714069. Review.

PMID:
28627309
3.

Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa.

Akuoko CP, Armah E, Sarpong T, Quansah DY, Amankwaa I, Boateng D.

PLoS One. 2017 Feb 13;12(2):e0171024. doi: 10.1371/journal.pone.0171024. eCollection 2017. Review.

4.

The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis.

Soleimani A, Rahmani Y, Farshchian N, Delpisheh A, Khassi K, Shahmohammadi A, Amirifard N.

J Cancer Prev. 2016 Dec;21(4):288-293. doi: 10.15430/JCP.2016.21.4.288. Epub 2016 Dec 30.

5.

Unique presentations of invasive lobular breast cancer: a case series.

Shakoor MT, Ayub S, Mohindra R, Ayub Z, Ahad A.

Int J Biomed Sci. 2014 Dec;10(4):287-93.

6.

Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.

Berkman A, F Cole B, Ades PA, Dickey S, Higgins ST, Trentham-Dietz A, Sprague BL, Lakoski SG.

Breast Cancer Res Treat. 2014 Nov;148(2):407-13. doi: 10.1007/s10549-014-3168-3. Epub 2014 Oct 18.

7.

Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey.

Oven Ustaalioglu BB, Bilici A, Yilmaz BE, Aliustaoglu M, Seker M, Vardar F, Gumus M.

Breast Care (Basel). 2014 May;9(2):123-7. doi: 10.1159/000360929.

8.

Gastrointestinal tract metastasis from tubulolobular carcinoma of the breast: a case report and review of the literature.

Wang G, Wang T, Jiang J, Zhou L, Zhao H.

Onco Targets Ther. 2014 Mar 18;7:435-40. doi: 10.2147/OTT.S57831. eCollection 2014.

9.

Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.

Simon R, Latreille J, Matte C, Desjardins P, Bergeron E.

Can J Surg. 2014 Feb;57(1):26-32.

10.

Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources.

Akinyemiju TF, Soliman AS, Copeland G, Banerjee M, Schwartz K, Merajver SD.

PLoS One. 2013 Apr 29;8(4):e61879. doi: 10.1371/journal.pone.0061879. Print 2013.

11.

Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.

Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS.

BMJ. 2012 Apr 26;344:e2718. doi: 10.1136/bmj.e2718.

12.

Identifying risk factors for disparities in breast cancer mortality among African-American and Hispanic women.

Tian N, Goovaerts P, Zhan FB, Chow TE, Wilson JG.

Womens Health Issues. 2012 May-Jun;22(3):e267-76. doi: 10.1016/j.whi.2011.11.007. Epub 2012 Jan 21.

13.
14.

Life after breast cancer: dealing with lymphoedema.

Cidón EU, Perea C, López-Lara F.

Clin Med Insights Oncol. 2011 Feb 7;5:9-14. doi: 10.4137/CMO.S6389.

15.

Advanced breast cancer incidence following population-based mammographic screening.

Autier P, Boniol M, Middleton R, Doré JF, Héry C, Zheng T, Gavin A.

Ann Oncol. 2011 Aug;22(8):1726-35. doi: 10.1093/annonc/mdq633. Epub 2011 Jan 20. Review.

16.

The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer.

Sprague BL, Trentham-Dietz A, Remington PL.

Cancer Causes Control. 2011 Jan;22(1):125-34. doi: 10.1007/s10552-010-9682-7. Epub 2010 Nov 16.

17.

Temporal trends in geographic disparities in small-area breast cancer incidence and mortality, 1988 to 2005.

Schootman M, Lian M, Deshpande AD, Baker EA, Pruitt SL, Aft R, Jeffe DB.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1122-31. doi: 10.1158/1055-9965.EPI-09-0966. Epub 2010 Mar 30.

18.

Gene expression profiling of peripheral blood cells for early detection of breast cancer.

Aarøe J, Lindahl T, Dumeaux V, Saebø S, Tobin D, Hagen N, Skaane P, Lönneborg A, Sharma P, Børresen-Dale AL.

Breast Cancer Res. 2010;12(1):R7. doi: 10.1186/bcr2472. Epub 2010 Jan 15.

19.

Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland.

Pan Q, Rosenthal DT, Bao L, Kleer CG, Merajver SD.

Clin Cancer Res. 2009 Dec 1;15(23):7441-6. doi: 10.1158/1078-0432.CCR-09-1361. Epub 2009 Nov 24.

20.

The multiplex bead array approach to identifying serum biomarkers associated with breast cancer.

Kim BK, Lee JW, Park PJ, Shin YS, Lee WY, Lee KA, Ye S, Hyun H, Kang KN, Yeo D, Kim Y, Ohn SY, Noh DY, Kim CW.

Breast Cancer Res. 2009;11(2):R22. doi: 10.1186/bcr2247. Epub 2009 Apr 28.

Supplemental Content

Support Center